Vaginal Dilators Market Report 2025

This vaginal dilators market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The vaginal dilators market size has grown strongly in recent years. It will grow from $23.2 billion in 2024 to $25.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing awareness of pelvic floor disorders, rise in prevalence of gynecological conditions, rising prevalence of cervical stenosis, increase in the number of surgical procedures, and increase in in demand for better quality medical instruments.

The vaginal dilators market size is expected to see strong growth in the next few years. It will grow to $34.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing incidence of vaginal agenesis, growing geriatric population, growing awareness of the significance of vaginal health, rising acceptance of pelvic health solutions, and growing demand for home-based therapies. Major trends in the forecast period include technological advancements, telemedicine integration, innovations in product design, advanced technologies, such as 3D imaging and flexible ultrasound transducers, and innovations in robotic surgery.

The growing prevalence of gynecological conditions is expected to drive the growth of the vaginal dilators market. Gynecological conditions encompass any disorders, diseases, or medical issues affecting the female reproductive system. Factors contributing to their prevalence include lifestyle changes, delayed childbearing, increased exposure to environmental toxins, and rising infection rates. Vaginal dilators are effective tools for managing and alleviating the impact of these conditions, improving patient outcomes and quality of life. For example, in 2024, Cancer Australia reported approximately 6,777 new cases of gynecological cancers in 2022, which resulted in about 2,111 female deaths that year. Consequently, the prevalence of gynecological conditions is driving demand for vaginal dilators.

Major companies in the vaginal dilators market are focusing on pioneering virtual clinical trials to assess the efficacy, patient comfort, and long-term therapeutic benefits of their products. Virtual clinical trials, also known as decentralized or remote trials, use digital tools and technologies to conduct research remotely. For example, in June 2024, Materna Medical Inc., a US-based developer of women’s pelvic health solutions, launched a new study called Prospective On Market Patient-reported Outcomes for Milli Vaginal Dilator (POMPOM). This trial aims to collect data on the effectiveness of the Milli Vaginal Dilator in alleviating discomfort related to vaginismus, a condition where involuntary pelvic floor muscle contractions cause pain or difficulty with penetration for many women.

In August 2024, Owen Mumford, a UK-based medical device solutions company, acquired Empelvic for an undisclosed amount. This acquisition aims to strategically strengthen Owen Mumford's pelvic and sexual health portfolio by integrating Empelvic's innovative products into its existing range, which includes vaginal dilators and vacuum therapy devices. Empelvic, a Denmark-based company, specializes in pelvic floor cushion technology and produces vaginal dilators.

Major companies operating in the vaginal dilators market are McKesson Corporation, Medline Industries LP, CooperSurgical Inc., MedGyn Products Inc., Femmax, CalExotics, GPC Medical Ltd., AvaCare Medical, Soul Source Inc., Panpac Medical Corporation, Velvi, Amielle, Intimate Rose, Hope&Her, Berman Center, NeuEve LLC, Dr. Berman's Dilators, Vuvatech Inc., Marina Medical Instruments Inc., Bien Aus Pty Ltd.

North America was the largest region in the vaginal dilators market in 2023. The regions covered in the vaginal dilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vaginal dilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Vaginal dilators are medical devices designed to stretch and expand the vaginal canal gently. They are typically used for therapeutic purposes and come in various sizes and shapes to accommodate different needs. The use of vaginal dilators is usually guided by a healthcare provider to ensure proper technique and to address any specific medical needs.

The main types of vaginal dilators are silicone vaginal dilator, magnetic vaginal dilators, others. Silicone vaginal dilators are medical devices made from soft, flexible silicone material, designed to help women gradually stretch their vaginal tissues. These are distributed through various distribution channels such as online stores, retail pharmacies, and others and are used in various applications such as hospitals, clinics, and others.

The vaginal dilators market research report is one of a series of new reports that provides vaginal dilators market statistics, including vaginal dilators industry global market size, regional shares, competitors with a vaginal dilators market share, detailed vaginal dilators market segments, market trends, and opportunities, and any further data you may need to thrive in the vaginal dilators industry. This vaginal dilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vaginal dilators market consists of sales of standard dilators, thermal dilators, and custom dilators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.